Replies to post #49440 on PharmaCyte Biotech Inc (PMCB)

[Gmc2020]

Of course, there is a lot of risk here, that's why it's 0.06 per share. If this gets to trials risk is reduced if it does well in trials risk is further reduced.

Pharma valuations treat risk like a discount rate on potential value... The market does as well